Lowering cholesterol with non-statin drugs
Part of Heart & circulation clinical trials.
This study tests if adding non-statin medications can help people with heart or blood vessel disease who still have high cholesterol despite taking statins. It aims to get their LDL (bad) cholesterol to a safer level.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a history of heart attack, stroke, or other arterial disease
- Your LDL cholesterol is not at target (below 55 or 70 mg/dL depending on your risk)
- You have seen a CommUnityCare provider in the past year
- You are not already taking non-statin drugs from another doctor or pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a clinical pharmacist-led team can help manage LDL cholesterol levels in patients with heart or blood vessel disease. It aims to improve care for people with conditions like coronary artery disease, stroke, or peripheral artery disease.
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
This study tests whether giving extra education to doctors and patients can help improve cholesterol management after a heart-related hospitalization. It aims to see if a simple program can make sure patients get the right testing and treatment for high cholesterol.
This study tests whether lowering cholesterol to very low levels (below 1.0 mmol/L) is more beneficial and safe than a slightly higher target (1.0–1.39 mmol/L) in patients with severe, recurrent heart or stroke events. You'll receive cholesterol-lowering medications and regular monitoring to see which target works best.
This program aims to improve how doctors manage cholesterol and other treatments for people with heart or blood vessel disease. It focuses on patients who also have diabetes or a genetic high-cholesterol condition, and are seen at Mass General Brigham.
This trial studies how to lower “bad” cholesterol (LDL) in people age 75 and older who have already had heart, brain, or leg/blood-vessel problems from blocked arteries. The goal is to see if the approach helps prevent further cardiovascular events (like heart attack or stroke).
Hear when a new ASCVD Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.